Kisspeptin
GnRH Pulse Regulator
Kisspeptin is the neuropeptide that sits at the top of the reproductive axis — it triggers GnRH (gonadotropin-releasing hormone) pulses from the hypothalamus, which drive LH and FSH release, and ultimately testosterone or estrogen production. Without kisspeptin signaling, the entire HPG axis is silent.
At a Glance
The discovery of kisspeptin as the GnRH gatekeeper in 2003 reshaped reproductive endocrinology. Mutations in kisspeptin or its receptor (KISS1R) cause complete hypogonadotropic hypogonadism — demonstrating that kisspeptin is not merely modulatory but essential for reproductive axis function.
It is studied in both male and female reproductive research — in women for IVF triggering and OHSS prevention; in men for hypogonadotropic hypogonadism and HPG axis characterization.
Phase 2 trials have explored kisspeptin for triggering oocyte maturation in IVF protocols, where it offers potential OHSS-reducing advantages over hCG triggers.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
KISS1R Agonism
Binds kisspeptin receptor (KISS1R/GPR54) on GnRH neurons, triggering GnRH pulse secretion — the primary activating signal for the entire HPG axis.
LH Surge Induction
In females, kisspeptin administration triggers the LH surge responsible for ovulation — studied as an alternative trigger to hCG in IVF protocols.
GnRH Pulse Regulation
Governs both pulse frequency and amplitude of GnRH release — providing fine-grained control over the downstream HPG axis in research protocols.
Reduced OHSS Risk
As an LH trigger in IVF, kisspeptin may produce a more physiological LH surge than hCG, potentially reducing ovarian hyperstimulation syndrome risk.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- IVF trigger — LH surge induction as alternative to hCG with potential OHSS reduction
- Hypogonadotropic hypogonadism — HPG axis characterization and GnRH pulse studies
- Male reproductive research — kisspeptin's role in testosterone pulse regulation
- Female reproductive biology — ovulation triggering and follicle maturation
- Puberty research — kisspeptin's role in pubertal HPG axis activation
- Reproductive aging — kisspeptin decline and HPG axis dysregulation
- Stress-induced reproductive suppression — kisspeptin neurons as integration point
Kisspeptin's position at the apex of the HPG axis makes it the most upstream point of pharmacological intervention in reproductive endocrinology research.
Compound Comparison
Kisspeptin, GnRH, and HCG represent three different levels of the HPG axis — each providing different control points for reproductive research.
| Aspect | Kisspeptin | GnRH (native) | HCG |
|---|---|---|---|
| HPG Level | Above GnRH (gatekeeper) | Hypothalamic | Pituitary/gonadal (LH analogue) |
| Primary Action | Triggers GnRH pulses | Triggers LH/FSH | Directly mimics LH |
| OHSS Risk (IVF) | Lower than hCG | Moderate | High |
| Research Utility | HPG axis gating studies | GnRH dynamics | LH/testosterone stimulation |
| Half-Life | ~28 min (kisspeptin-10) | ~2–4 min | ~24 hours |
The following reflects findings from published preclinical and clinical safety assessments where available.
Upstream HPG control — the most proximal pharmacological handle on the reproductive axis
Phase 2 IVF data — human evidence for LH surge induction with OHSS safety advantage
Natural physiological mechanism — endogenous peptide acting through its normal receptor pathway
Short half-life — kisspeptin-10's ~28-minute half-life requires careful dosing timing in research protocols
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026